WHAT ARE THE EFFECTS OF THIS DRUG?
↓ Weight 5.3-5.5 pounds at 52 weeks (577) loss may plateau at 26-34 weeks (568)
↓ Reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus
* Warnings:
↑ Ketoacidosis risk (difficulty breathing, vomiting, abdominal pain, confusion, sleepiness)
↑ Risks of serious UTI (urinary tract infections)
↑ Risk of bone mineral loss or bone fractures only identified in patients with renal impairment
↑ Risk of necrotizing fasciitis of the perineum (Fournier gangrene) is rare but potentially fatal.
Generic Name: Empagliflozin